The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats
- PMID: 1510711
- DOI: 10.1016/0006-2952(92)90395-y
The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats
Abstract
Sera from patients with halothane hepatitis contain immunoglobulin G (IgG) antibodies to trifluoroacetylated liver microsomal proteins of 100, 76, 59, 57 and 54 kDa, which are produced as a consequence of metabolism of halothane to trifluoroacetyl halide by cytochrome(s) P450. In the present study, the membrane topographies of the various antigens in rat liver microsomal fractions were investigated. Liver microsomal fractions from rats treated with halothane in vivo, and rat liver microsomal fractions which had been incubated with halothane in vitro, were used as the source of trifluoroacetyl antigens. The antigens were detected by immunoblotting. Whereas the 100, 76, 59 and 57 kDa antigens were solubilized from the microsomal membrane by either 0.1 M sodium carbonate or 0.1% (w/v) sodium deoxycholate, the 54 kDa antigen was not solubilized by 0.1% (w/v) sodium deoxycholate. In intact microsomal fractions, the 100, 76, 59 and 57 kDa antigens were not degraded appreciably by trypsin unless detergent was added to permeabilize the microsomal membrane. These results indicate that the 54 kDa antigen is an integral membrane protein, whereas the 100, 76, 59 and 57 kDa antigens are peripheral membrane proteins situated within the lumen of microsomal vesicles, and hence presumably located within the lumen of the endoplasmic reticulum in vivo.
Similar articles
-
Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.Proc Natl Acad Sci U S A. 1989 Jan;86(1):322-6. doi: 10.1073/pnas.86.1.322. Proc Natl Acad Sci U S A. 1989. PMID: 2911577 Free PMC article.
-
The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane.Chem Res Toxicol. 1992 May-Jun;5(3):406-10. doi: 10.1021/tx00027a014. Chem Res Toxicol. 1992. PMID: 1504264
-
Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.Drug Metab Dispos. 1990 Sep-Oct;18(5):788-93. Drug Metab Dispos. 1990. PMID: 1981738
-
Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens.Toxicology. 1995 Mar 31;97(1-3):199-224. doi: 10.1016/0300-483x(94)03010-y. Toxicology. 1995. PMID: 7716787 Review.
-
Mechanisms of halothane toxicity: novel insights.Pharmacol Ther. 1993;58(2):133-55. doi: 10.1016/0163-7258(93)90047-h. Pharmacol Ther. 1993. PMID: 8415876 Review.
Cited by
-
Drug-induced immunotoxicity.Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):443-51. doi: 10.1007/BF03189993. Eur J Drug Metab Pharmacokinet. 1998. PMID: 10323325 Review.
-
Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.Br J Clin Pharmacol. 1995 Oct;40(4):379-86. doi: 10.1111/j.1365-2125.1995.tb04560.x. Br J Clin Pharmacol. 1995. PMID: 8554940 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources